Press Coverage

Advancing data-driven surgery: Mauna Kea adds endomicroscope intelligence to robotic surgery toolkit

28 August 2017

Mauna Kea adds endomicroscope intelligence to robotic surgery toolkit 

By John Brosky, Contributing Writer, BioWorld MedTech

PARIS – The Food and Drug Administration granted 510(k) clearance to Paris-based Mauna Kea Technologies SA to apply the Celioflex UHD confocal miniprobes in robotic-assisted surgery procedures. 

The first utilization for a microscopic view during robotic surgery is expected to be for optical biopsies, enabling a surgeon to define margins around cancerous tissue in real time, Mauna Kea founder and CEO Sasha Loiseau told BioWorld MedTech

Latest News

Mauna Kea Technologies Announces Promising Results in New Application Combining Robotics and Cellvizio® for Precision Surgery in Head and Neck Cancers 

Mauna Kea Technologies Announces Promising Results in New Application Combining Robotics and Cellvizio® for Precision Surgery in Head and Neck Cancers 

Mauna Kea Technologies Secures Additional U.S. Artificial Intelligence Patent to Strengthen Endomicroscopy IP Complex 

Mauna Kea Technologies Secures Additional U.S. Artificial Intelligence Patent to Strengthen Endomicroscopy IP Complex 

Mauna Kea Technologies Reports Full Year 2024 Sales and Provides Strategic Update 

Mauna Kea Technologies Reports Full Year 2024 Sales and Provides Strategic Update